Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7533

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium trihydrate, showing the molecular arrangement including aromatic rings and functional groups characteristic of atorvastatin calcium.*

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

A line graph showing cumulative incidence (%) over 3.5 years comparing Atorvastatin and placebo. The x-axis represents time in years, and the y-axis shows cumulative incidence percentage. Atorvastatin is depicted with a solid line, and placebo with a dashed line, indicating lower cumulative incidence for Atorvastatin throughout the period.*

FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

A cumulative hazard graph showing the comparison between Atorvastatin and Placebo over a 5-year follow-up period. The Y-axis represents cumulative hazard percentage, and the X-axis shows time to the first primary endpoint in years. Atorvastatin is shown with a solid line and placebo with a dashed line, indicating a lower cumulative hazard for Atorvastatin over time with a hazard ratio (HR) of 0.63 and a p-value of 0.001.*

FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time, in years, for Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint (0 to 5 years), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2%). Two lines indicate outcomes for the two dosage groups. The graph also displays a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002.*

FDA Label Image

Label Image (Lbl500907533)

Label for ATORVASTATIN CALCIUM 80 mg film-coated tablets by A-S Medication Solutions. The label includes the NDC 50090-7533-0, storage instructions to keep between 68 to 77 degrees Fahrenheit, and indicates the package contains 90 tablets. It also notes each film-coated tablet contains atorvastatin equivalent to 86.79 mg atorvastatin calcium trihydrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.